Wall Street Wizardry
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Wall Street Wizardry

Politics

Trump signs executive order to make healthcare prices ‘transparent’

by admin February 26, 2025
February 26, 2025
Trump signs executive order to make healthcare prices ‘transparent’

President Donald Trump on Tuesday signed an executive order directing the departments of the Treasury, Labor, and Health and Human Services to make healthcare prices transparent.

The order directs the departments to ‘rapidly implement and enforce’ the Trump healthcare price transparency regulations, which he claims were slowed by the Biden administration.

The departments will ensure hospitals and insurers disclose actual prices, not estimates, and take action to make prices comparable across hospitals and insurers, including prescription drug prices.

In addition, they will be required to update their enforcement policies to ensure hospitals and insurers are in compliance with requirements to make prices transparent.

‘When healthcare prices are hidden, large corporate entities like hospitals and insurance companies benefit at the expense of American patients,’ the White House wrote in a statement. ‘Price transparency will lower healthcare prices and help patients and employers get the best deal on healthcare.’

The executive order notes a number of concerns with current healthcare pricing, including that prices vary between hospitals in the same region.

‘One patient in Wisconsin saved $1,095 by shopping for two tests between two hospitals located within 30 minutes of one another,’ according to the statement.

The White House claims one economic analysis found Trump’s original price transparency rules, if fully implemented, could deliver savings of $80 billion for consumers, employers and insurers by 2025.

It added that employers will lower their healthcare costs by an average of 27% on 500 common services by better shopping for care.

‘They’ll be able to check them, compare them, go to different locations, so they can shop for the highest-quality care at the lowest cost,’ Trump wrote in the statement. ‘And this is about high-quality care. You’re also looking at that. You’re looking at comparisons between talents, which is very important. And, then, you’re also looking at cost. And, in some cases, you get the best doctor for the lowest cost. That’s a good thing.’

The White House said American patients are ‘fed up with the status quo,’ with 95% saying healthcare price transparency is an important priority. More than 50% said it should be a top priority of the government.

In his first term, Trump took historic action by mandating that hospitals and insurers make prices public.

A lawsuit was filed against the Biden administration in 2023, alleging it did not enforce the prescription drug transparency requirements. 

‘While the prior Administration failed to prioritize further implementation and enforcement of these requirements, President Trump is delivering on his promises to make the healthcare system more affordable and easier to navigate for patients,’ according to the statement.

Fox News Digital previously reported the administration’s tariffs on China will affect drug costs.

Consumers are more dependent on China for medications for anxiety and other psychiatric disorders, such as antidepressants.

This post appeared first on FOX NEWS

previous post
Funeral held for Shiri Bibas and her sons after their remains handed over by Hamas
next post
White House confirms who was appointed as acting administrator of DOGE

Related Posts

Here’s what happened during President Donald Trump’s 5th...

February 22, 2025

Massachusetts suspect charged with attempting to assassinate a...

May 10, 2025

FORMER VICE PRESIDENT MIKE PENCE: Five years on,...

September 15, 2025

‘All-in’: GOP lawmakers divided on US involvement as...

June 14, 2025

Biden defends controversial autopen use for mass clemency...

July 14, 2025

Axed government watchdog says Trump has right to...

March 8, 2025

Former Trump officials reject whistleblower claim that FBI...

January 29, 2025

‘Peace through strength’: Trump and Netanyahu expected to...

February 4, 2025

Iran still wants a nuclear weapon despite ‘serious...

July 7, 2025

Billion-dollar Mexican cartel ops disrupted by Trump’s border...

January 30, 2025

    Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 2

      Universal’s ‘Wicked: For Good’ creates a unique marketing challenge

      January 26, 2025
    • 3

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 4

      Trump re-designates Iranian-backed Houthis as terrorists: ‘Threaten[s] security of American civilians’

      January 23, 2025
    • 5

      US security contractor will take charge of key checkpoint in Gaza as Israeli forces withdraw

      January 25, 2025
    • 6

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: wallstreetwizardry.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 wallstreetwizardry.com | All Rights Reserved